Literature DB >> 21654088

Fibrinogenolytic toxin from Indian monocled cobra (Naja kaouthia) venom.

C Chandra Sekhar1, Dibakar Chakrabarty.   

Abstract

A fibrinogenolytic toxin of molecular weight 6.5 kDa has been purified from the venom of Indian monocled cobra (Naja kaouthia) by repeated cation exchange chromatography on CM-sephadex C-50. The purified toxin did not show any phospholipase activity but was mildly hemolytic on human erythrocytes. This toxin, called Lahirin, cleaved fibrinogen in a dose- and time-dependent manner. The digestion process apparently started with the A alpha chain, and gradually other lower-molecular-weight chains were also cleaved to low-molecular-weight peptides. The fibrinolytic activity was completely lost after treatment with ethylene di-amine tetra acetic acid (EDTA). However, exposure to 100 degree C for 1 min or pre-treatment with phenyl methyl sulfonyl fluoride (PMSF) did not affect the fibrinolytic activity. Cleavage of di-sulphide bonds by beta-mercaptoethanol or unfolding the protein with 4 M urea caused complete loss of activity of pure Lahirin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21654088     DOI: 10.1007/s12038-011-9068-3

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  13 in total

1.  [Characterization of the substances of the bee venom].

Authors:  W NEUMANN; E HABERMANN
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1954

2.  The fibrin plate method for estimating fibrinolytic activity.

Authors:  T ASTRUP; S MULLERTZ
Journal:  Arch Biochem Biophys       Date:  1952-10       Impact factor: 4.013

3.  Mitochondrial DNA sequences from dried snake venom: a DNA barcoding approach to the identification of venom samples.

Authors:  C E Pook; R McEwing
Journal:  Toxicon       Date:  2005-09-12       Impact factor: 3.033

Review 4.  Anticoagulant proteins from snake venoms: structure, function and mechanism.

Authors:  R Manjunatha Kini
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

5.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

6.  An enzyme immunoassay for polymorphonuclear leucocyte-mediated fibrinogenolysis.

Authors:  R Bos; C J van Leuven; J Stolk; P S Hiemstra; H K Ronday; W Nieuwenhuizen
Journal:  Eur J Clin Invest       Date:  1997-02       Impact factor: 4.686

7.  Haemorrhagic protein of Russell's viper venom with fibrinolytic and esterolytic activities.

Authors:  D Chakrabarty; K Datta; A Gomes; D Bhattacharyya
Journal:  Toxicon       Date:  2000-11       Impact factor: 3.033

8.  Naja Kaouthia: two cases of Asiatic cobra envenomations.

Authors:  Gautam Khandelwal; Kenneth D Katz; Daniel E Brooks; Stephanie M Gonzalez; Colleen D Ulishney
Journal:  J Emerg Med       Date:  2007-01-17       Impact factor: 1.484

9.  Anti-coagulant activity of a metalloprotease: further characterization from the Indian cobra (Naja naja) venom.

Authors:  M S Kumar; V R Devaraj; B S Vishwanath; K Kemparaju
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

Review 10.  Snake bite.

Authors:  David A Warrell
Journal:  Lancet       Date:  2010-01-02       Impact factor: 79.321

View more
  2 in total

1.  Humanized-single domain antibodies (VH/VHH) that bound specifically to Naja kaouthia phospholipase A2 and neutralized the enzymatic activity.

Authors:  Charnwit Chavanayarn; Jeeraphong Thanongsaksrikul; Kanyarat Thueng-In; Kunan Bangphoomi; Nitat Sookrung; Wanpen Chaicumpa
Journal:  Toxins (Basel)       Date:  2012-07-19       Impact factor: 4.546

2.  Biochemical and biological characterization of Naja kaouthia venom from North-East India and its neutralization by polyvalent antivenom.

Authors:  Diganta Das; Nanjaraj Urs; Vilas Hiremath; Bannikuppe Sannanaik Vishwanath; Robin Doley
Journal:  J Venom Res       Date:  2013-11-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.